These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 185452)
21. [Evaluation of renal cyclic adenosine monophosphate, serum parathyroid hormone and phosphate reabsorption in recurrent calcium urolithiasis, healthy controls and hyperparathyroidism (author's transl)]. Schwille PO; Bornhof C; Thun R; Scholz D; Bötticher R; Schellerer W; Sigel A Klin Wochenschr; 1978 Jun; 56(12):601-6. PubMed ID: 210311 [TBL] [Abstract][Full Text] [Related]
22. [The diuresis of cyclic adenosine-3'5'-monophosphate (cAMP) in primary and secondary disorders of the parathyroid glands]. Kaukel E; Kuhlencordt F Dtsch Med Wochenschr; 1977 Nov; 102(44):1587-91. PubMed ID: 200407 [TBL] [Abstract][Full Text] [Related]
23. Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism. Kazama JJ; Gejyo F; Shigematsu T; Fukagawa M Ther Apher Dial; 2005 Aug; 9(4):328-30. PubMed ID: 16076376 [TBL] [Abstract][Full Text] [Related]
25. [Parathyroid function in patients on chronic intermittent hemodialysis (author's transl)]. Augustin R; Hackeng WH Klin Wochenschr; 1977 Aug; 55(16):811-6. PubMed ID: 409876 [TBL] [Abstract][Full Text] [Related]
26. [Secondary hyperparathyroidism: comparison of clinical findings with the degree of early parathyroid hyperplasia (author's transl)]. Ries P; Hebrmann R; Thiele J Dtsch Med Wochenschr; 1977 Sep; 102(39):1381-4. PubMed ID: 913257 [TBL] [Abstract][Full Text] [Related]
27. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917 [TBL] [Abstract][Full Text] [Related]
28. [Diagnostic value of the determination of nephrogenic cyclic AMP, and the value of cervical echography for localization in primary hyperparathyroidism. 13 cases]. Bentata-Pessayre M; Krivitzky A; Fond B; Gardin JP; Poncin J; Delzant G Ann Med Interne (Paris); 1984; 135(1):7-11. PubMed ID: 6322640 [TBL] [Abstract][Full Text] [Related]
35. Circulating forms of parathyroid hormone detected with an immunofluorometric assay in patients with primary hyperparathyroidism and in hyperparathyroidism secondary to chronic renal failure. Kunii IS; Vieira JG Braz J Med Biol Res; 2001 Dec; 34(12):1547-50. PubMed ID: 11717707 [TBL] [Abstract][Full Text] [Related]
36. Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism. Hung GU; Wang SJ; Lin WY Clin Nucl Med; 2003 Mar; 28(3):180-5. PubMed ID: 12592123 [TBL] [Abstract][Full Text] [Related]